Advos

CHARBONE Corporation will hold a webinar on May 29, 2026 to discuss its first quarter results, operational achievements, and upcoming milestones.

NanoViricides has entered into a securities purchase agreement for a registered direct offering expected to generate approximately $2 million, with proceeds to support development of its broad-spectrum antiviral drug NV-387.

Oncotelic Therapeutics announced first-quarter financial results and progress across its oncology, AI drug development, and CNS delivery initiatives, maintaining a $388 million valuation for its stake in GMP Biotechnology.

UPM Security now offers armed and unarmed guard deployment within 2-4 hours nationwide, enabling clients to reduce security vendors from four to one by integrating patrol, event, and disaster response services.

A2Z Cust2Mate Solutions Corp. reported Q1 2026 results with a contracted backlog of approximately $195 million for over 19,000 smart carts, signaling a shift from pilot programs to scaled commercial deployment.

Oncotelic Therapeutics is featured in a NetworkNewsAudio editorial discussing its strategic monetization agreement with Lunai Bioworks for its N2B delivery system, targeting biodefense and Alzheimer's disease, highlighting the company's role in overcoming blood-brain barrier challenges.

Pedro Habano's new single 'Payola' uses the controversial term for pay-to-play radio practices to deliver a salsa-infused reflection on life's inherent costs, blending vintage sounds with modern introspection.

LIXTE Biotechnology announced first-quarter 2026 results showing advancement of its PP2A inhibitor LB-100 in ovarian cancer trials and growth at its Liora Technologies subsidiary, signaling progress in its oncology pipeline.

H&H Forestry, a UK oak timber supplier, invites buyers to visit its yard to inspect oak before purchase, emphasizing quality, traceability, and expert guidance as demand for green oak doubles in warmer months.

Trilogy Metals Inc. announced its Arctic Project in Alaska has been accepted as a FAST-41 Covered Project, aiming to expedite federal environmental review and permitting for this critical mineral development.

SOLOWIN HOLDINGS (NASDAQ: AXG) subsidiary AX Coin has signed a non-binding MOU with INFINIOS to develop regulated wallet infrastructure and digital payment solutions, aiming to accelerate stablecoin adoption in the Gulf region.

MindBio Therapeutics is developing AI-powered voice analysis technology to detect drug and alcohol intoxication noninvasively, with potential applications in mining, aviation, construction, and law enforcement.

McEwen Inc.'s portfolio company McEwen Copper has appointed Societe Generale to arrange project debt financing for the Los Azules copper project in Argentina, aiming to secure a mix of funding sources as the project moves toward development.

Annovis Bio announced first-quarter 2026 progress including 85% enrollment in its pivotal Phase 3 Alzheimer’s trial and 40% enrollment in its Parkinson’s open-label extension, advancing buntanetap toward potential regulatory submission.

China's electric vehicle industry is under growing pressure from Western countries, reminiscent of Japan's car industry in the 1980s when exports were restricted, with implications for firms like NIO.

Ford Motor Company announced a pivot to energy storage, repurposing former EV battery factory space, leading to its best daily stock rally in six years.

The US Senate's version of the CLARITY Act aims to establish a comprehensive regulatory framework for digital assets, with implications for the crypto industry and traditional financial players.

New research from RMI reveals that wind and solar energy payments are matching or exceeding income from major farm commodities in some U.S. states, offering a financial lifeline to farmers facing erratic weather and rising costs.

NanoViricides reported progress in its broad-spectrum antiviral NV-387, including regulatory approval for a Phase II MPox trial in the Democratic Republic of Congo and FDA orphan drug designation for measles, highlighting its orphan-first strategy.

Lantern Pharma closed a $4.4 million registered direct offering, with potential additional proceeds from warrants, to advance its AI-driven oncology pipeline and commercialize its co-scientist platform.

A2Z Cust2Mate Solutions Corp. secured a $30 million credit facility from an Israeli bank to accelerate production and global deployment of its AI-powered smart shopping carts, preserving cash and avoiding equity dilution.